Edwards Lifesciences (EW) Operating Expenses (2009 - 2026)

Edwards Lifesciences' Operating Expenses history runs 18 years deep, the most recent figure standing at $822.6 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 13.54% year-over-year to $822.6 million; the TTM figure through Mar 2026 stood at $3.2 billion (up 9.22% YoY), while the FY2025 annual figure was $3.2 billion, up 10.23% from the prior year.
• Operating Expenses was $822.6 million for Q1 2026 at Edwards Lifesciences, up from $766.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $822.6 million in Q1 2026 to a low of $381.5 million in Q4 2022.
• Historically, Operating Expenses has averaged $696.8 million across 5 years, with a median of $719.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses tumbled 42.54% in 2022, then jumped 75.26% in 2023.
• A 5-year view of Operating Expenses shows it stood at $381.5 million in 2022, then surged by 75.26% to $668.6 million in 2023, then gained by 15.24% to $770.5 million in 2024, then slipped by 0.47% to $766.9 million in 2025, then climbed by 7.26% to $822.6 million in 2026.
• The last three Operating Expenses figures came in at $822.6 million (Q1 2026), $766.9 million (Q4 2025), and $795.4 million (Q3 2025), per Business Quant data.